Sangita Roy Chowdhury

Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations

Swetha Vasudevan, Efrat Flashner-Abramson, Heba Alkhatib et al. · npj Precision Oncology · 2021 · 29 citations · Full text

Medicine, Cancer Biology, Oncology +17

Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures

Swetha Vasudevan, Ibukun Adesoji Adejumobi, Heba Alkhatib et al. · Cancers · 2021 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +17

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance

Heba Alkhatib, Ariel M. Rubinstein, Swetha Vasudevan et al. · Genome Medicine · 2022 · 18 citations · Full text

Medicine, Bioinformatics, Oncology +17